NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) ("DocGo†or the "Company†), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its virtual care division, SteadyMD, is undertaking an immediate expansion of its clinical workforce, with plans to increase clinical staff by up to 50% over the coming weeks. The hiring initiative is driven by accelerating demand from its customer roster of top consumer, healthcare, and digital wellness. ...

Summary of DocGo FY Conference Call Company Overview - **Company**: DocGo (NasdaqCM:DCGO) - **Business Model**: A tech-driven provider of mobile health services, focusing on non-emergency medical transportation and various mobile health services including care gap closures, mobile phlebotomy, and remote patient monitoring, primarily for cardiac patients - **Operations**: Operates a fleet of approximately 900 vehicles and employs around 3,000 healthcare professionals, providing services across 50 states and the U.K. [5][6] Macro Environment and Regulatory Concerns - **Regulatory Shifts**: Ongoing discussions regarding Medicaid eligibility and administration could impact the care gap closure business if fewer individuals are covered [8][9] - **Demand Pressure**: A potential reduction in Medicaid coverage may increase demand for mobile health services as the existing healthcare system is already under pressure [9] - **AI Integration**: DocGo is leveraging AI to enhance efficiency in patient outreach and clinician operations [10] Business Segments and Growth Opportunities - **Revenue Segmentation**: Revenue is derived from two main segments: medical transportation (70% of revenue) and mobile health services, with the latter expected to grow rapidly [15][16] - **Care Gap Closure Business**: Currently working with six payers, with a cumulative assignment of 1.3 million lives. Revenue from this segment has quadrupled from 2024 to 2025, although it has lower margins compared to other mobile health services [18][19] - **Growth Focus**: The company is prioritizing investments in mobile health lines, particularly care gap closures and mobile phlebotomy, which are expected to yield higher margins in the future [19][20] Staffing and Operational Challenges - **Staffing Issues**: In 2025, DocGo had to outsource 26,000 transports due to staffing shortages, resulting in an estimated opportunity cost of $8-$9 million in revenue [40][41] - **Retention Strategies**: The company is focusing on improving recruitment and retention of EMTs and paramedics, which are critical to operations [42][49] - **Capacity Utilization**: The company aims to maintain a capacity utilization rate of 0.35 to 0.4 trips per 10-hour shift to optimize operations [45][48] Financial Guidance and M&A Strategy - **Revenue Guidance**: Projected revenue for 2026 is between $280 million and $300 million, reflecting organic growth without accounting for new contracts or M&A [54][55] - **M&A Opportunities**: DocGo is looking for tuck-in acquisitions to enhance mobile health capabilities and bolster operations in existing markets. The current market conditions present favorable opportunities for acquisitions [56][60] - **Balance Sheet Management**: The company has a solid balance sheet but is cautious about using equity for acquisitions. Recent cash collections from previous contracts are expected to support ongoing operations [61][62] Government Relations and Future Outlook - **Government Contracts**: The company is cautious about engaging in new government contracts due to working capital intensity but sees potential in population health programs under the new administration [63][66] - **Guidance Approach**: The company aims to provide conservative guidance to ensure that it can meet expectations without relying on uncertain factors [68][74] Conclusion DocGo is positioned to capitalize on growth opportunities in mobile health services while navigating regulatory challenges and operational hurdles. The focus on improving staffing, leveraging technology, and pursuing strategic acquisitions will be critical for achieving its financial targets in the coming years.

Group 1 - DocGo Inc. is a leading provider of technology-enabled mobile health and medical transportation services [1] - The company will participate in the 28th Annual Needham Growth Conference, with a fireside chat scheduled for January 14 at 1:30 PM Eastern Time [1] - A webcast of the fireside chat will be available on DocGo's investor relations website [1] Group 2 - DocGo is at the forefront of the proactive healthcare revolution, offering an innovative care delivery platform that includes mobile health services, remote patient monitoring, ambulance services, and a nationwide virtual care network [2] - The company aims to reshape traditional healthcare by providing high-quality, accessible care to patients in various settings [2] - DocGo's proprietary technology and dedicated field staff enhance patient care quality and improve operational efficiencies for healthcare facilities and providers [2]

Core Idea - The core idea of DocGo Inc. is to create a world-class mobile health care company that delivers medical care to patients where and when it is needed, aiming for better health outcomes and reduced strain on the healthcare system [2][3]. Company Overview - DocGo Inc. is focused on building a leading provider of tech-driven mobile care, with a foundational medical transportation business that operates similarly to an Uber-like model for medical transportation [4]. - The company has a rapidly growing care in the home business, all supported by a proprietary technology backbone designed specifically for delivering care [4].

Summary of DocGo Inc. Conference Call Company Overview - **Company**: DocGo Inc. - **Industry**: Mobile healthcare - **Core Idea**: Delivering medical care to patients where and when it is needed, aiming to improve health outcomes and reduce strain on the healthcare system [2][3] Key Business Segments - **Medical Transportation**: - Tech-driven platform providing medical transportation services, akin to an Uber-like experience [3][4] - Revenue projected to exceed $200 million this year, up from less than $100 million five years ago [8] - **Care-in-the-Home**: - Rapidly growing segment providing healthcare services directly in patients' homes [3][4] - Expected to serve over 150,000 patients this year [7][15] - **Remote Patient Monitoring**: - Monitoring over 50,000 patients, primarily in cardiac care [5][12] Financial Performance - **Q3 Revenue**: Approximately $71 million, with an adjusted gross margin of 33% [10][11] - **Adjusted EBITDA Loss**: Approximately $7.2 million [10] - **Cash Position**: Total cash on the balance sheet is $95.2 million, with no debt [11] - **Growth Guidance**: Projected revenue for next year is between $280 million to $300 million, indicating significant growth potential [9][38] Market Dynamics - **Total Addressable Market (TAM)**: Significant growth expected in home healthcare delivery, with CMS predicting a shift towards home-based care [3][18] - **Chronic Disease Management**: Addressing chronic diseases, which account for 90% of the U.S. healthcare spending, is a key focus [13][14] Competitive Advantages - **Tech Integration**: Proprietary tech platform integrated with hospital systems (e.g., Epic) to streamline patient flow and improve service delivery [24][25] - **Vertical Integration**: Combining technology, clinical staff, and transportation services to provide a seamless healthcare experience [28][30] - **Strategic Partnerships**: Collaborations with major hospital systems and health insurance companies to enhance service delivery and patient engagement [4][23][27] Growth Strategy - **Expansion Plans**: Focus on increasing patient density in existing markets and expanding to new markets through existing payer relationships [36][37] - **M&A Activity**: Recent acquisition of SteadyMD to enhance telehealth capabilities and expand clinical provider network [20][21][36] - **Patient-Centric Approach**: Emphasis on keeping patients out of hospitals and managing chronic conditions effectively [31][33] Additional Insights - **Patient Engagement**: High patient satisfaction reported, leading to better health outcomes [6][12] - **Service Offerings**: Over 40 different care services provided in-home, including screenings and vaccinations [15][22] - **Market Trends**: Anticipated shift of 30% of primary care market to non-traditional providers, indicating a growing opportunity for mobile healthcare [17][18] Conclusion DocGo Inc. is positioned as a leading provider in the mobile healthcare space, leveraging technology and strategic partnerships to deliver comprehensive care solutions. The company is on a growth trajectory with a strong financial foundation and a clear strategy to address the evolving needs of the healthcare market.

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of DocGo Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders.If you currently own DocGo stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial inc ...

Nov 26, 2025 7:35 AM Eastern Standard Time DocGo Announces Participation at Upcoming December Investor Conferences Share NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) ("DocGo†), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in December: Noble Capital Markets Emerging Growth Conference (December 3)Lee Bienstock, Chief Executive Officer will participate in 1x1 meet ...

Summary of DocGo Conference Call Company Overview - **Company Name**: DocGo - **Industry**: Mobile health and medical transportation services - **Stock Symbol**: DCGO (NASDAQ) - **Geographic Presence**: United States and United Kingdom - **Core Services**: Medical transportation, care in the home, remote patient monitoring, and technology-driven mobile healthcare solutions [1][2][3] Key Points and Arguments Business Model and Services - DocGo operates a tech-driven mobile health platform that includes ambulance services, medical transportation management, and home care services [2][4] - The company aims to deliver healthcare at any address, providing a turnkey solution for hospitals and facilities that prefer to outsource their transportation needs [4][5] - The use of "upskilled clinicians" allows for more efficient care delivery, utilizing qualified personnel for tasks that are often performed by overqualified individuals [5][6] Financial Performance - In 2023, DocGo's revenues peaked at over $600 million, largely due to non-recurring revenue from migrant-related services [15] - Projected revenue for 2025 is approximately $320 million, indicating a significant drop due to the transition away from non-core services [15] - Core medical transportation revenue has grown from $48 million in 2019 to over $200 million in 2023, demonstrating steady growth despite overall revenue fluctuations [16] Recent Developments - The acquisition of SteadyMD enhances DocGo's telehealth capabilities and expands its virtual care network across all 50 states [10][11] - The company has a strong balance sheet, with a cash balance of approximately $95 million and a focus on both organic and inorganic growth strategies [20][46] Market Position and Strategy - DocGo operates in a fragmented market with over 10,000 ambulance providers in the U.S., positioning itself as a scalable solution provider [37] - The company emphasizes vertical integration and a competitive technology advantage, which are critical for maintaining its market position [47][40] - Partnerships with health plan providers allow DocGo to reach patients who are delinquent in receiving necessary care, thereby increasing access and reducing overall healthcare costs [32][25] Challenges and Future Outlook - The company faces challenges related to accounts receivable, particularly from municipal contracts, but has successfully collected 96% of outstanding invoices [49] - The new mayoral administration in New York City may present both opportunities and risks, but DocGo's existing contracts with health and hospital systems are expected to continue [50][51] - The focus remains on closing care gaps and providing efficient healthcare solutions to prevent hospital readmissions and manage chronic diseases [22][24] Additional Important Information - DocGo's mobile health segment is expected to conduct over 150,000 home visits in 2025, reflecting the growing demand for home-based healthcare services [28] - The company is actively looking for acquisition opportunities in the healthcare sector, viewing current market conditions as favorable for growth [44][45] - Leadership includes experienced professionals from both healthcare and general management backgrounds, contributing to a well-rounded management team [47][39]

Core Insights - DocGo Inc. is a leading provider of technology-enabled mobile health and medical transportation services [1] - The company will participate in the 17th Annual Southwest Ideas Conference on November 19th, where CFO Norm Rosenberg will engage in 1x1 meetings and deliver a presentation at 2:20 PM ET [1] - A webcast of the event will be available for interested investors [1]

Financial Data and Key Metrics Changes - Total revenue for Q3 2025 was $70.8 million, down from $138.7 million in Q3 2024, primarily due to the sunset of migrant-related projects [22] - Excluding migrant-related programs, revenue increased by 8% to $62.4 million in Q3 2025 from $58 million in Q3 2024 [22] - Adjusted EBITDA for Q3 2025 was a loss of $7.1 million compared to an Adjusted EBITDA of $17.9 million in Q3 2024 [23] - Adjusted gross margin was 33% in Q3 2025, down from 36% in Q3 2024 [24] Business Line Data and Key Metrics Changes - Medical transportation services revenue increased to $50.1 million in Q3 2025 from $48 million in Q3 2024, driven by gains in nearly all U.S. markets [23] - Mobile health revenue for Q3 2025 was $20.7 million, down from $90.7 million in Q3 2024, with non-migrant mobile health revenues increasing by over 20% year-over-year [23] - The payer and provider vertical is expected to generate approximately $50 million in revenue in 2025, growing to $85 million in 2026, including $25 million from the SteadyMD acquisition [11][12] Market Data and Key Metrics Changes - The medical transportation business is expected to generate more than $200 million in revenue in 2025, with a projected Adjusted EBITDA contribution margin of approximately 12% [9] - Remote patient monitoring is operating at an annual run rate of approximately $15 million, with a greater than 10% Adjusted EBITDA contribution margin [12] Company Strategy and Development Direction - The company aims to build a robust, evergreen healthcare business and has a vision of bringing the capabilities of a doctor's office into a patient's living room [7][21] - The acquisition of SteadyMD is expected to enhance the company's virtual care capabilities and expand its clinical capacity [16][17] - The company plans to remain active in M&A to acquire traditional healthcare assets that can benefit from its technology and mobile health capabilities [18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to drive substantial value amid increasing healthcare costs and operational challenges [14] - The company anticipates a gradual abatement of investments in early-stage business lines over the course of 2026, aiming for profitability [19] - Management expects to exit 2026 with a cash balance of about $65 million, which will be the low point subject to buybacks or additional acquisitions [30] Other Important Information - The company has improved its balance sheet by paying off $30 million in debt and is now debt-free for the first time since late 2023 [27] - The company has collected approximately 96% of all migrant-related receivables from the inception of those programs [29] Q&A Session Summary Question: Can you help bridge the implied margins for the fourth quarter? - Management indicated that SteadyMD will contribute slightly to Q4 margins but will not have a material impact [33] Question: How does the EBITDA guidance for 2026 improve throughout the year? - Management expects the bulk of negative EBITDA will come in the first half of 2026, with improvements in the second half [37] Question: What is the expected revenue breakdown for 2026? - Management stated that there will be no migrant-related revenues for 2026, with a breakdown of about two-thirds transport and one-third mobile health [39] Question: Can you provide insights on payer-provider revenue growth? - Management confirmed that the $85 million for payer and provider in 2026 includes $25 million from SteadyMD and does not account for new deal closures [44] Question: What is the current view of the hospital spending environment? - Management noted that hospitals are cautious with budgets but are receptive to solutions that help lower costs and improve efficiency [66][69]